Saba Capital Management, L.P. bought HQL
April 23, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 48,203 shares of Abrdn Life Sciences Investors at $13.15 per share, a transaction worth $633.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
48,203
Price
$13.15
Total value
$633.9K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateApril 23, 2024
Filing dateApril 23, 2024
Shares owned after2,787,195
OwnershipIndirect
10b5-1 planNo
AmendedNo